Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The KRAS-Variant Genetic Test As a Marker of Increased Risk of Ovarian Cancer.

The KRAS-Variant Genetic Test As a Marker of Increased Risk of Ovarian Cancer. Rev Obstet Gynecol. 2010; 3(3):118-21.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.